Project Description
Updates from the CBTP Lab
The lab team at the Children’s Brain Tumor Project is working at an unprecedented pace in order to advance cures. Our team is focused on two strategic paths forward: (1) basic research toward breakthrough discoveries, and (2) translational research that will enable us to bring those discoveries to clinic.
Access to Experimental Drugs for Single-Patient Use Shows Promise in Pediatrics
June 28, 2019 - The Weill Cornell Medicine Children’s Brain Tumor Project is hopeful that single-patient use will work seamlessly in conjunction when designing patient-specific protocols based on genetic findings.
Annual Report
June 15, 2020 - Learn more about the Children's Brain Tumor Project and the impact we are making by reviewing this comprehensive annual report.
Combined Targeting of PI3K and MEK Effector Pathways via CED for DIPG Therapy
June 1, 2019 - A new research study from the CBTP lab entitled “Combined Targeting of PI3K and MEK Effector Pathways via CED for DIPG Therapy,” was published in Neuro-Oncology Advances on May 29, 2019.
IronMatt Supports the CBTP
May 28, 2019 - The Children’s Brain Tumor Project is proud to announce another project funded by the Matthew Larson Foundation (aka IronMatt) beginning late 2019.
Dr. Souweidane’s Ongoing DIPG Trial Findings Published in Lancet Oncology
July 10, 2018 - The Lancet Oncology published the highly anticipated results of Dr. Mark Souweidane’s first-ever dose escalation study using convection-enhanced delivery (CED) in patients with DIPG. The proven safety of this direct drug delivery approach will open many doors for new treatment options.